Futura Medical has advanced transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. MED2002 is a topical gel of glyceryl trinitrate (GTN) in FUM’s proprietary DermaSys technology. It is applied with a specially designed single-use applicator directly to the glans of the penis, rapidly absorbed to increase blood flow giving a fast onset of action, for the treatment of erectile dysfunction. It is very safe to use because local application eliminates many of the side effects associated with systemic prescription drugs (eg Viagra), such as headache and flushing.
14 Oct 2015
Maximising the return on MED2002
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Maximising the return on MED2002
Futura Medical plc (FUM:LON) | 35.5 -0.4 (-2.7%) | Mkt Cap: 107.0m
- Published:
14 Oct 2015 -
Author:
Mark Brewer -
Pages:
2
Futura Medical has advanced transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. MED2002 is a topical gel of glyceryl trinitrate (GTN) in FUM’s proprietary DermaSys technology. It is applied with a specially designed single-use applicator directly to the glans of the penis, rapidly absorbed to increase blood flow giving a fast onset of action, for the treatment of erectile dysfunction. It is very safe to use because local application eliminates many of the side effects associated with systemic prescription drugs (eg Viagra), such as headache and flushing.